Related Experiment Videos

SCE induction by indirect mutagens/carcinogens in metabolically active cultured mammalian cell lines

Basic Life Sciences
|January 1, 1984
PubMed

Insights

Certain tumor cell lines can activate mutagens/carcinogens to induce sister chromatid exchange (SCE). These cell lines offer a direct in vitro test system for genotoxicity screening without external activation, aiding metabolic pathway studies.

Area of Science:

  • Genetics
  • Toxicology
  • Cell Biology

Background:

  • Sister chromatid exchange (SCE) is a biomarker for genotoxicity.
  • Indirect mutagens/carcinogens require metabolic activation to become genotoxic.
  • Exogenous metabolic activation systems can be complex and variable.

Purpose of the Study:

  • To investigate the intrinsic mutagen-metabolizing capabilities of cultured mammalian cell lines.
  • To evaluate the potential of specific cell lines as direct in vitro SCE test systems.
  • To explore the relationship between metabolizing enzyme activity and SCE induction.

Main Methods:

  • Analysis of SCE in 20 cultured mammalian cell lines exposed to indirect mutagens/carcinogens.
  • Assessment of metabolizing enzyme activity in selected cell lines.
  • Comparison of SCE induction with enzyme activity and literature data.

Main Results:

  • Several human and rat tumor cell lines intrinsically metabolize mutagens/carcinogens into genotoxic forms that induce SCE.
  • These cell lines can serve as direct in vitro SCE test systems, eliminating the need for exogenous activation.
  • Metabolizing enzyme activity correlated with SCE inducibility, offering insights into metabolic pathways.

Conclusions:

  • Tumor cell lines with intrinsic metabolic capabilities are valuable tools for genotoxicity screening.
  • Direct-activating SCE test systems simplify the assessment of activation-dependent genotoxins.
  • Further research into these cell systems can advance genetic toxicology and understanding of carcinogenesis.

Related Concept Videos